ImmunologybioRxiv
Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis
A. Ignacio, M. Cipelli, T. Takiishi…·N. O. S. Camara
This study shows that blocking mTORC2 in CD11c+ myeloid cells reduces colitis by impairing DC migration and Th17 cell infiltration.
DOI 10.1093/jleuko/qiae084